» Articles » PMID: 36607593

Aryl Hydrocarbon Receptor in Glia Cells: A Plausible Glutamatergic Neurotransmission Orchestrator

Overview
Journal Neurotox Res
Publisher Springer
Specialty Neurology
Date 2023 Jan 6
PMID 36607593
Authors
Affiliations
Soon will be listed here.
Abstract

Glutamate is the major excitatory amino acid in the vertebrate brain. Glutamatergic signaling is involved in most of the central nervous system functions. Its main components, namely receptors, ion channels, and transporters, are tightly regulated at the transcriptional, translational, and post-translational levels through a diverse array of extracellular signals, such as food, light, and neuroactive molecules. An exquisite and well-coordinated glial/neuronal bidirectional communication is required for proper excitatory amino acid signal transactions. Biochemical shuttles such as the glutamate/glutamine and the astrocyte-neuronal lactate represent the fundamental involvement of glial cells in glutamatergic transmission. In fact, the disruption of any of these coordinated biochemical intercellular cascades leads to an excitotoxic insult that underlies some aspects of most of the neurodegenerative diseases characterized thus far. In this contribution, we provide a comprehensive summary of the involvement of the Aryl hydrocarbon receptor, a ligand-dependent transcription factor in the gene expression regulation of glial glutamate transporters. These receptors might serve as potential targets for the development of novel strategies for the treatment of neurodegenerative diseases.

Citing Articles

Aryl Hydrocarbon Receptor Involvement in the Sodium-Dependent Glutamate/Aspartate Transporter Regulation in Cerebellar Bergmann Glia Cells.

Silva-Parra J, Ramirez-Martinez L, Palafox-Gomez C, Sandu C, Lopez-Bayghen E, Vega L ACS Chem Neurosci. 2024; 15(6):1276-1285.

PMID: 38454572 PMC: 10958506. DOI: 10.1021/acschemneuro.4c00046.

References
1.
Ahmed S, Valen E, Sandelin A, Matthews J . Dioxin increases the interaction between aryl hydrocarbon receptor and estrogen receptor alpha at human promoters. Toxicol Sci. 2009; 111(2):254-66. PMC: 2999625. DOI: 10.1093/toxsci/kfp144. View

2.
Alt A, Weiss B, Ogden A, Knauss J, Oler J, Ho K . Pharmacological characterization of glutamatergic agonists and antagonists at recombinant human homomeric and heteromeric kainate receptors in vitro. Neuropharmacology. 2004; 46(6):793-806. DOI: 10.1016/j.neuropharm.2003.11.026. View

3.
Ambrogini P, Torquato P, Bartolini D, Albertini M, Lattanzi D, Di Palma M . Excitotoxicity, neuroinflammation and oxidant stress as molecular bases of epileptogenesis and epilepsy-derived neurodegeneration: The role of vitamin E. Biochim Biophys Acta Mol Basis Dis. 2019; 1865(6):1098-1112. DOI: 10.1016/j.bbadis.2019.01.026. View

4.
Arriza J, Eliasof S, Kavanaugh M, Amara S . Excitatory amino acid transporter 5, a retinal glutamate transporter coupled to a chloride conductance. Proc Natl Acad Sci U S A. 1997; 94(8):4155-60. PMC: 20584. DOI: 10.1073/pnas.94.8.4155. View

5.
Azevedo F, Carvalho L, Grinberg L, Farfel J, Ferretti R, Leite R . Equal numbers of neuronal and nonneuronal cells make the human brain an isometrically scaled-up primate brain. J Comp Neurol. 2009; 513(5):532-41. DOI: 10.1002/cne.21974. View